Thu 24th Apr 14, 09:18
In the first quarter of 2014 Barclays' Fixed Income, Credit and Commodities (FICC) unit continued to face many of the challenges seen in the second half of 2013, although outside of investment banking its units were putting in a resilient performance, the lender said in a brief trading update provided ahead of this morning's Annual General Meeting which is set to start at 11:00.
Search news for stories that mention a company:
Show only the stories that interest you with news filter.
The German IFO institute's business confidence index rose to 111.2 in April from 110.7 in the month before. 42 minutes ago
Technology developer Pace reported a good start to the financial year at its annual general meeting on Thursday, saying forecast demand for both current and new products was building as the year progressed. 58 minutes ago
Titanium mineral producer Kenmare Resources announced a near-doubling of production in the last three months after expanding its Moma mine in Mozambique. 1 hour ago
European stocks began the session registering moderate gains following the advance seen in after-hours trading in shares of US technology giant Apple. 1 hour ago
After Apple reported quarterly earnings that beat consensus estimates thanks to better-than-expected iPhone sales, markets began to shift gears and focus on its possible inclusion in the Dow Jones stock market index. 1 hour ago
0920: In the first quarter Barclays' Fixed Income, Credit and Commodities (FICC) unit continued to face the same challenges which it saw in the second half of 2013, the lender said in a brief trading update ahead of this morning's Annual General Meeting which is set to start at 11:00. 32 minutes ago
Disclaimer: This news feed is provided by Digital Look Ltd. BullBearings Ltd do not necessarily share the views expressed within the stories. The stories are for general information purposes only and not a solicitation or personal reccomendation to deal. BullBearings Ltd accepts no liability or responsibility for any of the content contained in the information provided by Digital Look Ltd.
In this, the first of a series of four articles, I will explain some forex misconceptions are, and outline the feature that is the real “holy grail” of the market. In the following three parts, I will show how a robust trading strategy can be built that will give the new or aspiring trading an edge with an overwhelming probability of profitability over the long run.
In order to begin our journey, it helps to begin with an allegorical story, in order to demonstrate the nature and challenge of the struggle of trading.
Those who have followed me for some years will know I am a fan of seasonality and as I have explained in previous updates, financial markets do not go up or down evenly throughout the year in a nice orderly straight line; that would be far too easy.
If we invested $10,000 in the Dow Jones on 1st November and and then taken our money out on April 30st from 1950 to date we would now have over $950,000. We would have been out of the market May until end of October each year missing a few crashes in the process.
The USD/CHF pair fell during the session on Friday, but did so in a relatively tame manner, leading me to believe there are still opportunities for short-selling.
After all, we have seen for strong selloffs as far as daily candles are concerned, and then have finally see the market settle down for the Friday session.
Cloud computing services provider Nasstar (NASA) has been transformed by its acquisition of rival e-know.net. The integration of the operations is already far advanced and the business should be profitable this year.
e-know.net was established by David Redwood in 2000 and it was much larger than Nasstar, which paid £13m in cash and shares for the company in January and raised £10.5m from a placing at 5p a share.
Shares in Abcam (ABC), the provider of antibodies for the life sciences research and testing sector, have fallen by more than a quarter in recent weeks after a profit warning at the beginning of last month, with some investors clearly now having doubts about the long term future for the company. But new research might indicate things aren't as bad as some doomsayers believe.
Independent antibody search engine CiteAb has released new data today that suggests that this is a temporary dip for Abcam, with a brighter future ahead.